Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Controlled, Phase 1 Study to Investigate Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers

NCT05165628 is registered in ClinicalTrials.gov with Cynata Therapeutics Limited as lead sponsor.

NCT NCT05165628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05165628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Controlled, Phase 1 Study to Investigate Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers
Lead sponsor
Cynata Therapeutics Limited
Phase
Phase 1
Overall status
Completed
Start date
January 4, 2022
Completion date
September 24, 2024
Enrollment
30 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous ulcer, diabetic foot ulcer